AUSTIN, Texas--(BUSINESS WIRE)--CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and ...
AUSTIN, Texas--(BUSINESS WIRE)--July 11, 2006--On Wednesday, 21 June 2006, Janet Woodcock, FDA Deputy Commissioner for Operations and Chief Operating Officer, announced during her DIA presentation, ...
TUCSON, Ariz., and AUSTIN, Texas - October 18, 2017 -Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne ...
The Huntington's Disease Regulatory Science Consortium (HD-RSC), launched in March 2018 by the Critical Path Institute (C-Path) and CHDI Foundation, today, along with the Clinical Data Interchange ...
The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path), and TransCelerate BioPharma, Inc. (TransCelerate), announce the open availability of a CDISC Therapeutic ...
As always, CDISC begins the year with a flurry of activity (do keep an eye on the website for regular updates and news on the standards). In addition to the CDISC standards themselves, the CDISC Board ...
AUSTIN, Texas--(BUSINESS WIRE)--The Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has released the requirements of clinical trial data submission in the ...
areas that are important to public health. “The CFAST initiative continues to drive progress in developing therapeutic area standards for some of the world’s most pressing health concerns,” said ...
TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX - September 11, 2017 - Critical Path Institute (C-Path), CHDI Foundation, Inc. (CHDI), and The Clinical Data Interchange Standards Consortium (CDISC) announce ...
CDISC and the National Organization forRare Disorders (NORD(R)) have announced a partnership to develop global data standards for rare diseases. The data standards will be released in a Therapeutic ...
Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne Muscular Dystrophy Therapeutic Area User Guide ( TAUG-DMD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results